SCHEME 2. Synthesis of the 6′(R)-Azidomethyl
LNA-Thymidine Monomer and a Double-Headed
Nucleosidea
from 6. The potential of the 6′(R)-position for the design of
functional LNA and subsequent nanostructures will be illustrated
in the near future. Nevertheless, simple modeling starting from
LNA-modified duplexes1,28 indicates the present pro-R position
of the 6′-carbon to be the most favorable position of the two
pointing into the minor groove. Hence, we consider the present
method for stereoselective preparation of 6′(R)-branched LNA
as extremely convenient, and the application of the key
compounds 6, 11 and 12 for the preparation of functionalized
LNA derivatives is in progress.
a Reagents and conditions: (a) MsCl, pyridine, DCM (90%); (b) NaN3,
DMF (57%); (c) Zn, AcOH (31%); (d) N1-propragylthymine, Na ascorbate,
CuSO4 ·5H2O, tBuOH, H2O (75%); (e) H2, Pd/C, EtOH (67%).
Experimental Section
Synthesisof(1R,3R,4R,6S,7S)-7-benzyloxy-1-benzyloxymethyl-
6-bromomercurimethyl-3-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]-
heptane (7). To a solution of the olefin 4 (2.82 g, 6.1 mmol) in
THF (150 mL) was added mercury(II) trifluoroacetate (3.90 g, 9.11
mmol), and the mixture was stirred for 12 h. The mixture was
concentrated under reduced pressure, and the residue was dissolved
in DCM (150 mL). A 10% aqueous solution of NaBr (50 mL) was
added, and the mixture was stirred vigorously for 30 min. The two
phases were separated, and the organic phase was treated with
another 10% aqueous solution of NaBr (50 mL). After separation,
the organic phase was washed with water (3 × 50 mL), dried
(Na2SO4), and concentrated under reduced pressure to give the
product (4.45 g, 98%) as a white foam: Rf 0.42 (EtOAc in hexane,
FIGURE 2. N-Type conformation and mutual NOE contacts indicated
in the 6′-methylenebranched LNA derivatives (based on NMR experi-
ments on 11 and 12, R ) N3 or NH2).
Both observations proved the 6′(R)-configuration as demon-
strated in Figure 2.
Obviously, both the hydroxy group of 6 and the amine of 12
can be used in nucleophilic derivatizations. Nevertheless, we
decided to apply the azide functionality of 11 in combination
with terminal alkynes in Huisgen-type [3 + 2] cycloadditions,
which can be performed with complete regioselectivity, giving
only 1,4-disubstituted triazoles by a Cu(I) catalysis.24 Recently,
this reaction type has been intensively applied as a result of the
concept of click chemistry introduced by Sharpless and co-
workers.25 The reaction is very robust, it tolerates almost all
functional groups, it can be performed in aqueous solutions,
and it displays high atom economy giving no side products. In
line of our ongoing program on double-headed nucleosides,9,11
we decided to use the present azide for the decoration of LNA
with an additional nucleobase. N1-Propargylthymine26 and
compound 11 were reacted following a standard protocol with
microwave heating24,27 to give efficiently the double-headed
nucleoside 13. Global deprotection by hydrogenolysis afforded
compound 14. This compound is currently being studied as a
building block in nucleic acid secondary structures such as our
recently investigated three-way junctions or DNA-zipper motifs.11
In summary, we have proved the applicability of mercury(II)
trifluoroacetate for forming a 6′-hydroxymethyl modified LNA
monomer that is otherwise obtainable only in lower yields and
a higher number of steps.8 Hence, compound 6 was obtained
in approximately 22% overall yield over the 13 steps from
1,2;5,6-di-O-isopropylidene-R-D-allofuranose, whereas the dif-
ferently protected analogue by Swayze and Seth was obtained
in 19% yield as an epimeric mixture over 17 steps.8 Furthermore,
the utility of compound 6 for derivatization was illustrated by
the preparation of first the azide 11 and then of the double-
headed nucleoside 14 in 26% overall yield over the four steps
1
1:1 v/v); H NMR (300 MHz, CDCl3) δ 9.10 (m, 1H, NH), 7.49
(s, 1H, H-6), 7.31-7.18 (m, 10H, Ph), 5.57 (s, 1H, H-1′), 4.61-4.55
(m, 6H, H-2′, 2 × CH2Ph, H-6′), 3.99 (s, 1H, H-3′), 3.68 (s, 2H,
2 × H-5′), 2.25 (m, 1H, H-7′), 1.91 (m, 1H, H-7′), 1.55 (s, 3H,
CH3), 13C NMR (75 MHz, CDCl3) δ 163.8 (C-4), 149.9 (C-2),
137.3, 136.8 (Ph), 134.7 (C-6), 128.8, 128.8, 128.7, 128.7, 128.6,
128.3, 128.0, 127.9 (Ph), 110.2 (C-5), 87.3, 86.7 (C-1′, C-4′), 79.8,
78.3, 77.5 (C-2′, C-3′, C-6′), 73.95, 72.5 (2 × CH2Ph), 64.7 (C-
5′), 31.9 (C-7′), 12.4 (CH3); HRMALDI MS m/z calcd for
C26H27HgBrN2O6 [M + Na]+ 767.0651, found 767.0618.
Synthesis of (1S,3R,4R,6R,7S)-7-Benzyloxy-1-benzyloxymethyl-
6-(2,2,6,6-tetramethylpiperidin-1-yl)oxymethyl-3-(thymin-1-yl)-2,5-
dioxabicyclo[2.2.1]heptane (8). To a stirred solution of the mercuric
derivative 7 (2.0 g, 2.68 mmol) in anhydrous DMF (13 mL) was
added TEMPO (3.15 g, 20.2 mmol). The reaction mixture was
stirred at 0 °C, and a solution of sodium boron hydride (477 mg,
12.6 mmol) and TEMPO (3.15 g, 20.2 mmol) in anhydrous DMF
(13 mL) was added dropwise. The mixture was stirred at 0 °C for
1 h and filtered through celite with precaution to remove the
mercury particles. The sinter was rinsed with dichloromethane (150
mL). The combined filtrates were concentrated under reduced
pressure and coevaporated with xylene. The residue was purified
by column chromatography (20-50% EtOAc in hexane) to afford
the product (2.50 g, 77%) as a white foam: Rf 0.46 (EtOAc in
hexane, 1:1 v/v); IR (KBr,νmax cm-1) 3433.9, 3187.5, 3065.9,
2929.4, 1693.9, 1455.14, 1361.2, 1269.7, 1103.4, 1055.9; 1H NMR
(300 MHz, CDCl3) δ 7.59 (s, 1H, H-6), 7.36-7.25 (m, 10H, Ph),
5.54 (s, 1H, H-1′), 4.69-4.55 (m, 4H, CH2Ph), 4.36 (s, 1H, H-2′),
4.31 (m, 1H, H-6′), 4.13-4.08 (m, 2H, H-3′, H-5′), 3.99 (m, 2H,
H-7′), 3.79 (d, 1H, J ) 11.4 Hz, H-5′), 1.60 (s, 3H, CH3), 1.43 (br
s, 6H, 3 × CH2), 1.13 (br s, 6H, 2 × CH3), 1.00 (br s, 6H, 2 ×
CH3); 13C NMR (75 MHz, CDCl3) δ 163.7 (C-4), 149.7 (C-2),
137.8, 137.0 (Ph), 135.1 (C-6), 128.7, 128.6, 128.3, 128.1, 128.0,
127.7 (Ph), 110.2 (C-5), 87.9 (C-4′), 86.6 (C-1′), 77.6 (C-3′), 76.7
(C-6′), 76.5 (C-2′), 74.0 (CH2Ph), 73.7 (C-7′), 72.6 (CH2Ph), 64.8
(C-5′), 60.1, 60.0 (C(CH3)2), 39.8, 39.7 (CH2C(CH3)2), 33.4, 32.8
(C(CH3)2), 20.5, 20.1 (C(CH3)2), 17.2 (CH2CH2CH2), 12.4 (CH3);
HRMALDI MS m/z calcd for C35H45N3O7 [M + Na]+ 642.3150,
(24) (a) Tornøe, C. W.; Christensen, C.; Meldal, M. J. Org. Chem. 2002,
67, 3057–3064. (b) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless,
K. B. Angew. Chem., Int. Ed. 2002, 41, 2596–2599.
(25) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int. Ed. 2001,
40, 2004–2021.
(26) Lindsell, W. E.; Murray, C.; Preston, P. N.; Woodman, T. A. J.
Tetrahedron 2000, 56, 1233–1245.
(27) Kocˇalka, P.; Andersen, N. K.; Jensen, F.; Nielsen, P. ChemBioChem
2007, 8, 2106–2116.
(28) Nielsen, K. E.; Singh, S. K.; Wengel, J.; Jacobsen, J. P. Bioconjugate
Chem. 2001, 11, 228–238.
J. Org. Chem. Vol. 73, No. 17, 2008 6893